These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25836608)

  • 1. Evaluation of PIMA point-of-care CD4 analyzer in Yunnan, China.
    Liang J; Duan S; Ma YL; Wang JB; Su YZ; Zhang H; Ou CY; Hao L; Qi MS; Bulterys M; Westerman L; Jiang Y; Xiao Y
    Chin Med J (Engl); 2015 Apr; 128(7):890-5. PubMed ID: 25836608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of PIMA analyzer detecting CD4 cell count of venous and capillary blood in HIV-infected individuals].
    Su YZ; Jia MH; Jiang Y; Xiao Y; Shi YH; Chen HC; Yan WY; Yang L; Yang CJ; Chen M; Dong LJ; Ma YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1001-5. PubMed ID: 24507227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
    Diaw PA; Daneau G; Coly AA; Ndiaye BP; Wade D; Camara M; Mboup S; Kestens L; Dieye TN
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):e103-11. PubMed ID: 21909029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil.
    Pinto IC; Sabidó M; Pereira AB; Mello MB; de Melo Xavier Shimizu A; Protti BL; Benzaken AS
    PLoS One; 2015; 10(4):e0121400. PubMed ID: 25905775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of the performance of the Pima™ CD4 for point of care testing.
    Scott LE; Campbell J; Westerman L; Kestens L; Vojnov L; Kohastsu L; Nkengasong J; Peter T; Stevens W
    BMC Med; 2015 Jul; 13():168. PubMed ID: 26208867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
    Galiwango RM; Lubyayi L; Musoke R; Kalibbala S; Buwembo M; Kasule J; Serwadda D; Gray RH; Reynolds SJ; Chang LW
    PLoS One; 2014; 9(3):e88928. PubMed ID: 24614083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube.
    Kohatsu L; Bolu O; Schmitz ME; Chang K; Lemwayi R; Arnett N; Mwasekaga M; Nkengasong J; Mosha F; Westerman LE
    PLoS One; 2018; 13(8):e0202018. PubMed ID: 30138398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.
    Makadzange AT; Bogezi C; Boyd K; Gumbo A; Mukura D; Matubu A; Ndhlovu CE
    PLoS One; 2016; 11(7):e0157546. PubMed ID: 27388763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon.
    Sagnia B; Mbakop Ghomsi F; Gutierrez A; Sosso S; Kamgaing R; Nanfack AJ; Nji N; Ambada G; Lissom A; Tchouangueu TF; Ngu Ndengkoh L; Domkam I; Nchinda G; Ndjolo A
    AIDS Res Ther; 2020 Aug; 17(1):53. PubMed ID: 32799909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
    Negedu-Momoh OR; Jegede FE; Yakubu A; Balogun O; Abdullahi M; Badru T; Oladele EA; Agbakwuru C; Khamofu H; Torpey K
    PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of two POC technologies for CD4 count in Morocco.
    Elharti E; Abbadi H; Bensghir R; Marhoum El Filali K; Elmrabet H; Oumzil H
    AIDS Res Ther; 2020 Jun; 17(1):31. PubMed ID: 32522235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.
    Mtapuri-Zinyowera S; Chideme M; Mangwanya D; Mugurungi O; Gudukeya S; Hatzold K; Mangwiro A; Bhattacharya G; Lehe J; Peter T
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):1-7. PubMed ID: 20622679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda.
    Namuniina A; Lutwama F; Biribawa VM; Kizza D; Kabuubi BR; Kitandwe PK; Mpendo J; Nanvubya A; Ssempiira J; Nalutaaya A; Ssetaala A; Welsh S; Price MA; Kiwanuka N; Bagaya BS
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):382-387. PubMed ID: 30560683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India.
    Thakar M; Mahajan B; Shaikh N; Bagwan S; Sane S; Kabra S; Rewari B; Shaukat M; Singh N; Trevor P; Paranjape R
    AIDS Res Ther; 2012 Sep; 9(1):26. PubMed ID: 22998738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.
    Wade D; Daneau G; Aboud S; Vercauteren GH; Urassa WS; Kestens L
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):e98-107. PubMed ID: 24853304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.
    Manabe YC; Wang Y; Elbireer A; Auerbach B; Castelnuovo B
    PLoS One; 2012; 7(4):e34319. PubMed ID: 22536323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
    Sukapirom K; Onlamoon N; Thepthai C; Polsrila K; Tassaneetrithep B; Pattanapanyasat K
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):141-7. PubMed ID: 21709568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts.
    Bwana P; Vojnov L; Adhiambo M; Akinyi C; Mwende J; Prescott M; Mwau M
    PLoS One; 2015; 10(12):e0145586. PubMed ID: 26720601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.